Amundi
EDIT icon

Amundi’s Editas Medicine EDIT Stock Holding History

Amundi’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,294
Closed -$10.4K – 2162
2024
Q3 		$10.4K Hold
3,294
– – ﹤0.01% 1927
2024
Q2 		$15.3K Hold
3,294
– – ﹤0.01% 1861
2024
Q1 		$18.3K Hold
3,294
– – ﹤0.01% 1912
2023
Q4 		$30.4K Sell
3,294
-3,049
-48% -$26.8K ﹤0.01% 1924
2023
Q3 		$44.7K Hold
6,343
– – ﹤0.01% 1882
2023
Q2 		$52.3K Hold
6,343
– – ﹤0.01% 1892
2023
Q1 		$43.5K Hold
6,343
– – ﹤0.01% 1899
2022
Q4 		$54.2K Hold
6,343
– – ﹤0.01% 1694
2022
Q3 		$79K Buy
+6,343
New +$98.8K ﹤0.01% 1593

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi's EDIT Position: Q4 2024 in Review

Amundi sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 3,294 shares — an estimated $10.4K sold.

Amundi first reported a position in EDIT in Q3 2022 and held it in 9 quarters. The position peaked at $79K in Q3 2022. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Amundi reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 3,294 Editas Medicine shares in Q4 2024, an estimated $10.4K.
  • Amundi first reported a position in Editas Medicine in Q3 2022 and held it in 9 quarters.
  • Amundi's Editas Medicine position peaked at $79K in Q3 2022.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.